You have 8 free searches left this month | for more free features.

Zemplar

Showing 26 - 50 of 86

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hyperparathyroidism, Secondary Trial in San Fermo della battaglia (CO) (standard care, Optimal (I. iPTH control:

Unknown status
  • Hyperparathyroidism, Secondary
  • standard care
  • Optimal (I. iPTH control: Zemplar®,Mimpara®; phosphorous control: Renvela®, Phoslo®, Osvaren®, Foznol®,Maalox®; calcium control: calcium and vitamin D
  • San Fermo della battaglia (CO), Italy
    Azienda Ospedaliera Sant'Anna
Sep 12, 2015

Cardiorenal Syndrome, Chronic Allograft Nephropathy Trial in Rotterdam, Yekaterinburg (Paricalcitol, Calcitriol,

Completed
  • Cardiorenal Syndrome
  • Chronic Allograft Nephropathy
  • Rotterdam, South Holland, Netherlands
  • +1 more
May 14, 2015

Proteinuria Trial in Oslo (Paricalcitol)

Completed
  • Proteinuria
  • Oslo, Norway
    Renal Section, Oslo University Hospital, Rikshospitalet
Mar 29, 2016

Nephropathy Trial (Paricalcitol)

Terminated
  • Nephropathy
  • (no location specified)
Feb 20, 2015

Healthy Trial in Ahmedabad (Paricalcitol Capsules, 4 mcg)

Completed
  • Healthy
  • Paricalcitol Capsules, 4 mcg
  • Ahmedabad, Gujarat, India
    Lambda Therapeutic Research Ltd
Dec 18, 2014

Solid Tumor Trial in Buffalo (gemcitabine HCl, paricalcitol)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 8, 2014

Quality of Life in Greek Hemodialysis Patients Receiving Zemplar

Completed
  • Chronic Kidney Disease
  • Secondary Hyperparathyroidism
    • Arta, Greece
    • +10 more
    Jul 29, 2014

    Anemia, Chronic Kidney Disease Trial in Naples (Paricalcitol, Calcitriol)

    Completed
    • Anemia
    • Chronic Kidney Disease
    • Naples, Italy
      Federico II University
    Jul 29, 2014

    Intravenous Paricalcitol on Cardiac Morbidity in Chronic Kidney

    Completed
    • Secondary Hyperparathyroidism
    • +2 more
      • Graz, Austria
      • +11 more
      Jun 9, 2014

      Secondary Hyperparathyroidism, Chronic Kidney Disease Trial in United States (Paricalcitol, Calcitriol)

      Completed
      • Secondary Hyperparathyroidism
      • Chronic Kidney Disease
      • Chicago, Illinois
      • +3 more
      Aug 4, 2014

      Zemplar Capsules in Therapy of Secondary Hyperparathyroidism

      Completed
      • Chronic Kidney Disease
      • Secondary Hyperparathyroidism
        • Montana, Bulgaria
        • +68 more
        Sep 12, 2014

        Chronic Kidney Disease Trial in Seattle (Paricalcitol, Placebo)

        Completed
        • Chronic Kidney Disease
        • Seattle, Washington
          University of Washington
        Apr 9, 2014

        Coronary Artery Disease, Chronic Kidney Disease, Hypovitaminosis D Trial in Philadelphia (paricalcitol, )

        Terminated
        • Coronary Artery Disease
        • +3 more
        • Philadelphia, Pennsylvania
          Thomas Jefferson University
        May 13, 2014

        Program of Zemplar in End Stage Chronic Kidney Disease and

        Completed
        • Secondary Hyperparathyroidism
          • Almetyevsk, Russian Federation
          • +12 more
          Feb 28, 2014

          When Treating Chronic Kidney Disease Paricalcitol in German and

          Completed
          • Kidney Insufficiency
          • Secondary Hyperparathyroidism
            • Feldkirch, Austria
            • +86 more
            Dec 11, 2014

            Paricalcitol IV Administered to Venezuelan Patients

            Terminated
            • Chronic Kidney Disease Stage V
            • Hemodialysis
              • Acarigua, Venezuela
              • +7 more
              Nov 7, 2014

              Chronic Kidney Disease Trial in Danderyd (Zemplar)

              Completed
              • Chronic Kidney Disease
              • Zemplar
              • Danderyd, Stockholm, Sweden
                Karolinska Institute at Danderyd University Hospital
              Sep 4, 2013

              Heart Failure Trial in Boston (Paricalcitol)

              Withdrawn
              • Heart Failure
              • Boston, Massachusetts
                Massachusetts General Hospital
              Aug 15, 2013

              Chronic Kidney Disease Trial in Indianapolis (Paricalcitol)

              Completed
              • Chronic Kidney Disease
              • Indianapolis, Indiana
                Roudebush VA Medical Center
              Apr 2, 2013

              Transplant; Failure, Kidney, Renal Disease, End Stage, Hyperparathyroidism, Secondary Trial in Scottsdale, Rochester

              Completed
              • Transplant; Failure, Kidney
              • +2 more
              • Paricalcitol
              • Corticosteroid Avoidance Immune Suppression Protocol
              • Scottsdale, Arizona
              • +1 more
              May 9, 2013

              Type 2 Diabetes, Chronic Kidney Disease Trial in United States (Zemplar, Placebo)

              Unknown status
              • Type 2 Diabetes
              • Chronic Kidney Disease
              • Zemplar
              • Placebo
              • Atlanta, Georgia
              • +3 more
              Feb 12, 2013

              Vitamin D Receptor Activators in Patients Ages 0 to 16 With

              Terminated
              • Secondary Hyperparathyroidism
              • End-Stage Renal Disease
              • Birmingham, Alabama
              • +17 more
              May 17, 2013

              Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (paricalcitol, zoledronic acid)

              Terminated
              • Multiple Myeloma and Plasma Cell Neoplasm
              • Buffalo, New York
                Roswell Park Cancer Institute
              Jan 31, 2013

              Practices and Quality of Life With Paricalcitol Capsules in

              Completed
              • Secondary Hyperparathyroidism
              • Chronic Kidney Disease
                • Kalmar, Sweden
                • +9 more
                Jan 22, 2014

                Time to Achieving Maintenance Dose of Zemplar® in Treatment of

                Completed
                • Kidney Failure, Chronic
                  • Budapest, Hungary
                  • +10 more
                  Jan 11, 2013